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Traditional knowledgeAbstract Variations in antioxidant and anti-viral activities (against InﬂuenzaAP/R/8 (H1N1) virus)
between the leaves and stem bark of selected medicinal plants were studied. Malin Darby canine
kidney (MDCK) cells were used for the viral infection and the antiviral activity of the extracts was
studied using sulphorhodamine B (SRB) assay. The stembark of the plants includingStrychnosminor,
Diotacanthus albiﬂorus, Strychnos nux-vomica and Chloroxylon swietenia showed higher ﬂavonoid
contents as well as 2,20-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) scavenging activ-
ity when compared with their leaves. In case of 1,1-diphenyl-2-picrylhydrazyl (DPPH) activity, the
stem bark of S. nux-vomica and leaf extract of C. swietenia showed the highest activity. Based on
the IC50 values, the stem bark extracts of Cayratia pedata (20.5 lg/mL) and S. minor (22.4 lg/mL)
showed high antiviral activity. In the mean-time S. nux-vomica, C. swietenia and C. swietenia bark
extracts showed cytotoxicity to the MDCK cells. When comparing the stem bark and leaves the
content of gallic acid, ferulic acid, o-coumaric acid, total ﬂavonoids (TFC) and total phenols (TPC)
was higher in stembark and hence their anti-viral activity was high. Further study based on themetab-
olites against H1N1 can reveal the potential of therapeutic compounds against the viral disease.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Plants are the major source of discoveries of novel therapeutic
compounds because of their high secondary metabolite con-
tent. These metabolites can be classiﬁed into various groups
such as ﬂavonoid, phenolic, alkaloids etc. Based on the content
and type the metabolites inﬂuence the antioxidant activity
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in plants is highly regulated by environmental conditions
(Mariya et al., 2003). South India is one of the major resources
for a plethora of diverse medicinal plants and is reported for
traditional use against various diseases. In fact the origin
and diversity of Siddha medicine which was followed and prac-
ticed by Siddhas was found to be evidence for the diversity of
the medicinal plant in South India. Even today many people
are using plant sources for their primary medical needs not
only in South India but all over the world (Goleniowski
et al., 2006; Gurib-Fakim, 2006). Because the valuable infor-
mation on medicinal plants was passed on to children and
mostly orally their medicinal properties have became scattered
(Nadembega et al., 2011). From the little knowledge that we
have about the uses of such plants for treating various diseases
it will be possible to garner information on new therapeutic
production which could be very useful in the long run.
Humans are prone to infection by various viral diseases and
H1N1 is found to be an important problem. Its morbidity and
mortality are rather high. These viral diseases spread all over
the country and lead to severe health problems in children
and the elderly. Even though vaccines are available for ﬂu,
their success rate on the elderly is less (Wang et al., 2006).
These viruses are reported for their immunity against various
drugs because of mutation (Stein et al., 2009). In this context,
the discovery of newer medicines is required and hope rests on
plants as the major source. Chinese and Japanese formulated
herbal medicines such as Shahakusan, hochuekkito, Jinchai
and Lianhuaqingwen capsules and reported for high anti-viral
activity (Dan et al., 2013; Hokari et al., 2012; Zhong et al.,
2013; Duan et al., 2011). Fifty medicinal plant extracts of
rainforests like Borneo, Sarawak, and Malaysia, were studied
and reported for H1N1 (Rajasekaran et al., 2013).
Strychnos minor, Diotacanthus albiﬂorus, Strychnos nux-
vomica, Chloroxylon swietenia, and Cayratia pedata are some
of the important medicinal plants of South India in which
the leaves and stem bark were used against various diseases.
Available literature on these traditional medicinal plants illus-
trates that different parts of C. swietenia are used for scorpion
bites and the stem is used against cold and cough (Ratnam and
Raju, 2008; Reddy, 2008). Roots and leaves were also reported
for healing headache (Nilip and Gouri, 2013). In the case of
C. pedata the anti-inﬂammatory activity with water and
alcohol extracts was well studied (Rajendran et al., 2013).
D. albiﬂorus showed anti-microbial activity with leaf extracts
(Duraipandiyan et al., 2006). S. minor was used against poison
bites by tribals of South India (Ayyanar, 2008). The genus
Strychnos that was extensively reviewed for its activity against
various diseases is discussed by Rajesh et al., 2011. The root
bark of S. nux-vomica was reported for its anti-diarrhoeal
potential by Shoba and Thomas (2001). The anti-inﬂammatory
properties of the metabolites like strychnine, brucine, strych-
nine N-oxide isolated from the seeds were reported by Yin
et al. (2003). Even though these medicinal plant parts like
leaves and stem bark were studied for various diseases includ-
ing cold, their activity against virus was not studied.
The main objective of the present study was to ﬁnd the anti-
viral activity of the medicinal plants against H1N1 and to ﬁnd
the variations in activity among the leaves and stem bark.
Findings of the results might be helpful for antiviral drug
formulations.2. Materials and methods
2.1. Chemicals
All the solvents used for the study were of HPLC grade and
the chemicals were purchased from Sigma Aldrich (St. Louis,
MO, USA). The cell culture medium and chemicals were
purchased from Welgene, 150-Seongseo Industrial Complex
Bukro, Dalseogu, Daegu, 704-948 Republic of Korea.
2.2. Plant materials
The leaves (L) and stem bark (s) of the medicinal plants such
as S. minor (MP-L1, MPs1), D. albiﬂorus (MP-L2, MPs2),
S. nux-vomica (MP-L3, MPs3), C. swietenia (MP-L4, MPs4),
and C. pedata (MP-L5, MPs5) were separately collected from
Tamil Nadu, South India and were shade dried. The plants
were identiﬁed and conﬁrmed for the genus and species by
an ethno-botanist from Pachaiyappa’s college, Chennai, Tamil
Nadu, India during the collection of samples.
2.3. Extraction of medicinal plants
Shade dried samples (0.1 g) were separately weighed and
extracted with 1 ml of methanol. After sonication for a period
of 10 min, the samples were centrifuged at 8000 rpm for
10 min. The supernatant was collected and the extraction pro-
cedure was repeated. All the collected supernatant was pored
together and evaporated under speed vac. The resulting pellet
was redissolved with DMSO for cell culture studies and with
methanol for the analysis of polyphenols, ﬂavonoid content,
antioxidant studies and for HPLC analysis.
2.4. Cell culture
Inﬂuenza AP/R/8 virus (H1N1) and Malin Darby canine kid-
ney (MDCK) cells were purchased from American type culture
collection (ATCC) and used for the present study. The MDCK
cells were grown by using Dulbecco’s modiﬁed eagle’s medium
(DMEM) added with 10% of foetal bovine serum (FBS) and
1% of antibiotic–antimycotic solution (100·). MDCK cells
were maintained at 32 C with 5% of CO2 in a relative humid-
iﬁed cell culture incubator.
2.5. Antiviral assay
In a 96 well plate the MDCK cells (2 · 104) were seeded and
allowed to grow for a period of 24 h. After that the cells were
washed twice with phosphate buffered saline (PBS) and the
inﬂuenza AP/R/8 virus (diluted as 5 · 103 with DMEM
medium contained trypsin–EDTA) was introduced for the
infection. Virus solution (90 lL) and medicinal plant extracts
(10 lL) of different dilutions (0.1, 1, 10 and 100 lL) were
placed onto the 96 well plates with three replicates. These
plates are incubated for a period of 48 h under CO2 incubator.
After incubation (48 h) the medium was removed and washed
twice with PBS before ﬁxing the cells. The cells were ﬁxed by
following a sequence of steps such as incubating the cells with
70% of acetone for 1 h at 4 C followed by removing the
solvent and dried the cells at 60 C under hot air oven.
Figure 1 Comparative analysis between leaves and stem bark
extracts of selected medicinal plants for their total ﬂavonoid (A)
and total phenolic (B) content.
Figure 2 Comparative analysis between leaves and stem bark
extracts of selected medicinal plants for their anti-oxidant activity
against DPPH (A) and ABTS (B).
Table 1 Cytotoxicity of the medicinal plant extracts against
H1N1 virus.
S. No. Name Toxicity of the extracts
IC50 CC50 TI
1 MP-L1 46.69 1026.07 21.97
2 MP-s1 22.43 100 4.45
3 MP-L2 60.09 100 1.66
4 MP-s2 33.98 50 1.47
5 MP-L3 33.36 20 0.59
6 MP-s3 23.60 40 0.59
7 MP-L4 ND 50 ND
8 MP-s4 ND 3.95 ND
9 MP-L5 65.99 100 0.60
10 MP-s5 20.50 18.30 0.89
11 Oseltamivir 6.44 100 15.51
Control drug – Oseltamivir; IC50 – inhibitory concentration of
50%; CC50 – cytotoxicity concentration of 50%; TI – therapeutic
index.
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The SRB assay was performed by adding 100 lL of SRB
(0.4 mg/L) reagent to the dried 96 wells and incubated over-
night. After incubation the SRB reagent was decanted and
washed thrice with 1% of acetic acid. The plates were dried
at 60 C and the cell morphology was observed under micro-
scope (reﬂected light microscope) at 40· magniﬁcation. The
images were taken and compared for the antiviral activity.
The 96 well plates containing the cells were treated with
10 mM of Tris base and incubated overnight. SRB strains in
the cells were completely dissolved in the buffer and were read
under a 96 well plate reader at 510 nm to calculate the inhibi-
tion concentration of 50% (IC50), cytotoxic concentration of
50% (CC50) and therapeutic index (TI).
2.7. Total ﬂavonoid content (TFC)
The total TFC content of the plant samples was measured by
adding 180 lL of 90% diethylene glycol and 20 lL of 1 N
NaOH in a 96 well plate containing 20 lL of methanol extract.
The optical density of the samples was measured at 515 nm
using a micro plate reader (Spectra max plus384, Molecular
devices, USA) after 15 min of incubation. Calculations were
made based on the naringin concentration and are expressed
in mg/g of sample.2.8. Total polyphenol content (TPC)
The total TPC content of the plant samples was measured by
adding 100 lL of 0.2 N Folin–Ciocalteu’s phenol reagent and
Figure 3 Comparative analysis between leaves and stem bark extracts of selected medicinal plants for their anti-viral activity against
H1N1 by SRB assay. MP – medicinal plants; control drug – Oseltamivir.
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taining 20 lL of methanol extract. The optical density of the
samples was measured after 1 h of incubation at 750 nm. The
calculations were made based on the values obtained for gallic
acid at different concentrations and expressed in mg/g of
sample.2.9. Free radical scavenging activity
The 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 2,20-azino-
bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) radical
scavenging activity of the samples was measured by following
the procedures of Maria John et al. (2014, 2015). 20 lL of
methanol extract was mixed with 180 lL of DPPH (0.5 mM)
and ABTS reagents were incubated for 20 min and 7 min.
The absorbance was measured at 515 nm and 750 nm for the
respective analysis using a micro plate reader.2.10. Secondary metabolite analysis by HPLC
The methanol extracts were analysed by HPLC (Agillent 1100,
USA) to ﬁnd the metabolic variations. Water and acetonitrile
containing 0.1% formic acid served as mobile phases A and B
with the ﬂow rate of 1 ml/min. The samples were analysed
using C18 column with a diode array detector (DAD) at
254 nm. Total run time of the sample was 40 min and based
on the individual standards retention time (tR) the metabolite
identiﬁcation was made.
2.11. Data analysis
Data analysis was performed using different softwares such as
Statistica 7 for metabolite comparison, heat map for metabo-
lite correlation studies and SPSS for statistical analysis of the
biochemical analysis. For the individual metabolite analysis,
Figure 4 Metabolic variations of leaves and stem bark of
medicinal plants analysed by HPLC. tR – retention time; log10
values of the peak area was plotted in the x-axis; MP – medicinal
plants.
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3. Results and discussion
3.1. Total phenolic and ﬂavonoid contents of the medicinal plants
Total ﬂavonoid and polyphenol contents of the medicinal
plant extracts were compared and are presented in Fig. 1.
Results revealed that the ﬂavonoid content was the highest
for MP-s2 (24.82 mg/g) followed by MP-L5 (22.30 mg/g).
MP-s5 (11.36 mg/g) followed by MP-L3 (11.88 mg/g) had the
lowest ﬂavonoid content among the samples analysed. Among
the ﬁve plants tested, the stem bark showed a high ﬂavonoid
content with MP-s2, MP-s3 and MP-s4 when compared to
their leaves (MP-L2, MP-L3 and MP-L4). In the case of total
polyphenol content, MP-s2 registered a high (29.73 mg/g) phe-
nolic content followed by MP-L1. Mp-s5 and MP-s4 registered
the lowest content in terms of polyphenols. Here the stem bark
of MP-s2 and s3 showed a high phenolic content than that of
their leaves (Fig. 1B).
3.2. Free radical scavenging potential of the selected medicinal
plants
The leaves and stem bark of the selected medicinal plants were
compared for their antioxidant potential using DPPH and
ABTS assay (Fig. 2). The plants and their parts such as leaves
and bark showed variation in terms of DPPH and ABTS activ-
ities. MP-L3 (57.51%) followed by MP-s4 (53.93%) resulted in
high DPPH scavenging potential whereas MP-L5 followed by
MP-s5 had the lowest activity. In the case of MP-L1, MP-s1
and MP-L2 possess the same activity in terms of statistical
analysis (Fig. 2A). In terms of ABTS activity, the stem bark
extract of the medicinal plants MP-s1, MP-s2, MP-s3 and
MP-s4 showed high antioxidant activity. Among all the sam-
ples analysed MP-s2 (84.17%) followed by MP-s1 (76.05%)
registered high scavenging potential. Here also MP-L5 and
MP-s5 registered lowest scavenging activity (Fig. 2B).
3.3. Antiviral activity against H1N1
For anti-viral activity assay, the extract of 0.1, 1, 10 and
100 lL was used (Table 1). Results of the cells treated with dif-
ferent concentrations of medicinal plant extracts and the stan-
dard drug (Oseltamivir) are presented in Fig. 3. The leaves and
stem bark showed variations in their antiviral activity. Based
on the IC50 and CC50 values the antiviral activities of the
extracts were compared. MP-s5 and MP-s1 showed high anti-
viral activity in terms of IC50 values (20.5 lg/mL and 22.4 lg/
mL) whereas the CC50 values of the samples are 18.3 lg/mL
and >100 lg/mL. These two samples are stem bark and
showed high activity against H1N1 virus. MP-s3, MP-L3,
MP-s2, MP-L1, MP-L2 and MP-L5 also showed good antivi-
ral activity (IC50 value of 23.60 lg/mL, 33.3 lg/mL, 33.9 lg/
mL, 46.7 lg/mL, 60.1 lg/mL and 65.2 lg/mL). These samples
showed CC50 value of 20 lg/mL, 50 lg/mL, 1026 lg/mL,
>100 lg/mL and >100 lg/mL, respectively. We observed
that MP-L4 and MP-s4 did not show antiviral activity because
their cytotoxicity level was high with the MDCK cells being
observed (Table 1).3.4. Metabolite analysis by HPLC
The extracts were analysed for their metabolic variations and
compared with their antioxidant and antiviral activities. The
metabolites such as gallic acid, o-coumaric acid, ferulic acid
and quercetin contents were predominantly changed among
the samples. When comparing the plant extracts gallic acid
and o-coumaric acid levels are high in MP-s1 followed by
MP-L1 being observed. Whereas ferulic acid and quercetin
contents were high with MP-L4 followed by MP-s4 (Fig. 4).
Figure 5 Correlation study between metabolites and cytotoxicity against H1N1.
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activities is presented in Fig. 5. Results revealed that gallic
acid, ferulic acid, o-coumaric acid, and TFC and TPC contents
were positively correlated with antioxidants and antiviral
activity (IC50). Based on the results it was clear that the anti-
viral activity was not only dependent on their total phenolic
or ﬂavonoid content but also their individual metabolic levels.
The phenolic compounds and ﬂavonoids serve as potent
antioxidant source (Mariya John et al., 2009) and used against
various human diseases. The ﬂavonoids are reported for anti-
viral activity including HIV, hepatitis B and inﬂuenza (Jassim
and Naji, 2003; Li et al., 2008; Liu et al., 2008; Mori et al.,
2008). The medicinal plants particularly the bark of the plants
showed high phenolic and ﬂavonoid contents and resulted in
their high activity against ABTS. MP-s4 extracts reported
against cold and inﬂuenza infection also show cold as common
symptom (Ratnam and Raju, 2008), but the leaves and stem
extracts showed cytotoxicity to the MDCK cells. When com-
paring the leaves and stem bark of the medicinal plants, the
stem bark of MP-s2, MP-s3 and MP-s4 showed high ﬂavonoid
contents and hence these stem barks were used traditionally
against various diseases. Even though the phenolic content
level of MP-5 (C. pedata) was low, their antiviral activity
against H1N1 was high. This plant was traditionally used for
anti-inﬂammatory activity as their activity against virus was
high (Rajendran et al., 2013; Maria John et al., 2014, 2015).
Based on the studies of the phenolic and ﬂavonoid contents,
it was clear that the high phenolic content resulted in cell tox-
icity in spite of their high antioxidant activity. The metabolic
correlation with antiviral activity suggests that coumaric acid,
quercetin, TFC and TPC show positive correlation whereas
ferulic acid shows negative correlation. Previous reports of
quercetin resulted in inhibitory properties of several viruses
and the present study also conﬁrms the activity by positive
correlation (Mucsi and Pragai, 1985). As stated by Hwa Jung
Choi et al. (2009), the quercetin 3-rhamnoside was strongly
active against inﬂuenza virus (Choi et al., 2009). Quercetin,
TFC and TPC were positively correlated with IC50 valuesuggesting the possibility of those plant extracts against
H1N1 in the mean time these metabolites showed negative cor-
relation with CC50. Coumaric acid showed positive correlation
with IC50 as well as CC50, hence this phenolic acid contains
antiviral activity along with cytotoxicity to the MDCK cells.
This may be the reason for the cytotoxicity of the cells by high
phenolic content containing plants. According to the above
results the stem bark with high ﬂavonoid contents showed
low cytotoxicity with high antiviral activity. MP-s5, MP-s1,
MP-s3, MP-L3, MP-s2, MP-L1, MP-L2 and MP-L5 showed
good antiviral activity and can be an alternative source for
the development of new therapeutic compounds.
4. Conclusions
Based on the above it was clear that the extracts from stem
bark and leaves showed variations in their metabolic contents
resulting in changes in antiviral activity against H1N1. The
metabolite correlation study revealed that the ﬂavonoids
directly correlated with anti-viral activity but high phenolic
content resulted with cytotoxicity to the MDCK cells. The
metabolic variations and antiviral activity of the plant extracts
suggest that it can be used as a source for new therapeutic
compound development against H1N1 since this viral disease
was spread worldwide.
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